Chien‐Te K. Tseng

10.9k total citations · 2 hit papers
84 papers, 6.1k citations indexed

About

Chien‐Te K. Tseng is a scholar working on Infectious Diseases, Immunology and Animal Science and Zoology. According to data from OpenAlex, Chien‐Te K. Tseng has authored 84 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 28 papers in Immunology and 27 papers in Animal Science and Zoology. Recurrent topics in Chien‐Te K. Tseng's work include SARS-CoV-2 and COVID-19 Research (55 papers), Animal Virus Infections Studies (26 papers) and Viral gastroenteritis research and epidemiology (23 papers). Chien‐Te K. Tseng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (55 papers), Animal Virus Infections Studies (26 papers) and Viral gastroenteritis research and epidemiology (23 papers). Chien‐Te K. Tseng collaborates with scholars based in United States, China and Saudi Arabia. Chien‐Te K. Tseng's co-authors include Gary R. Klimpel, C. J. Peters, Xinrong Tao, Shinji Makino, Lanying Du, Anurodh Shankar Agrawal, Shibo Jiang, Tania Garron, Krishna Narayanan and Robert B. Couch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Chien‐Te K. Tseng

81 papers receiving 6.0k citations

Hit Papers

Immunization with SARS Coronavirus Vaccines Leads to Pulm... 2012 2026 2016 2021 2012 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
    2012 399 citations Chien‐Te K. Tseng, Tania Garron et al. PLoS ONE profile →
  2. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
    2019 374 citations Anurodh Shankar Agrawal, Abdullah Algaissi et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chien‐Te K. Tseng United States 45 4.3k 1.4k 1.3k 1.1k 1.0k 84 6.1k
V. Stalin Raj Netherlands 39 5.5k 1.3× 1.1k 0.7× 2.4k 1.8× 1.0k 1.0× 1.1k 1.0× 69 7.4k
Bo‐Jian Zheng Hong Kong 49 4.5k 1.0× 2.0k 1.4× 2.0k 1.5× 2.2k 2.0× 2.5k 2.3× 121 9.4k
Jian‐Piao Cai China 40 4.3k 1.0× 602 0.4× 779 0.6× 762 0.7× 1.1k 1.0× 148 5.7k
Julian L. Leibowitz United States 42 2.9k 0.7× 967 0.7× 2.4k 1.8× 960 0.9× 906 0.9× 134 5.7k
Katja C. Wolthers Netherlands 39 3.9k 0.9× 963 0.7× 1.1k 0.8× 603 0.6× 2.7k 2.6× 134 6.6k
Jie Zhou China 40 2.8k 0.6× 1.3k 0.9× 363 0.3× 1.3k 1.1× 1.6k 1.6× 129 5.7k
Weijin Huang China 30 3.4k 0.8× 425 0.3× 477 0.4× 1.1k 1.0× 737 0.7× 186 4.8k
Po Tien China 43 2.8k 0.6× 2.8k 1.9× 768 0.6× 2.9k 2.7× 1.4k 1.4× 169 7.6k
Boyd L. Yount United States 48 6.7k 1.5× 923 0.6× 3.0k 2.2× 1.1k 1.0× 802 0.8× 111 8.1k
Jacqueline D. Reeves United States 31 2.9k 0.7× 1.8k 1.2× 358 0.3× 883 0.8× 1.1k 1.0× 62 5.2k

Countries citing papers authored by Chien‐Te K. Tseng

Since Specialization
Citations

This map shows the geographic impact of Chien‐Te K. Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Te K. Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Te K. Tseng more than expected).

Fields of papers citing papers by Chien‐Te K. Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Te K. Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Te K. Tseng. The network helps show where Chien‐Te K. Tseng may publish in the future.

Co-authorship network of co-authors of Chien‐Te K. Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Te K. Tseng. A scholar is included among the top collaborators of Chien‐Te K. Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Te K. Tseng. Chien‐Te K. Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tat, Vivian Y, et al.. (2024). Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. Pathogens. 13(7). 539–539. 1 indexed citations
3.
Fisher, Tal, Krishna Narayanan, Makoto Kuroda, et al.. (2022). Parsing the role of NSP1 in SARS-CoV-2 infection. Cell Reports. 39(11). 110954–110954. 43 indexed citations
4.
Massey, Shane, Michael J. Hansen, Courtney L. Erskine, et al.. (2022). Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Science Advances. 8(34). eabm8563–eabm8563. 9 indexed citations
5.
Xing, Jing, Rama Shankar, Meehyun Ko, et al.. (2022). Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants. iScience. 25(10). 105068–105068. 1 indexed citations
6.
Vatansever, Erol C., Kai S. Yang, Aleksandra Drelich, et al.. (2021). Bepridil is potent against SARS-CoV-2 in vitro. Proceedings of the National Academy of Sciences. 118(10). 82 indexed citations
7.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2021). Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 12(1). 3984–3984.
8.
9.
Curreli, Francesca, Aleksandra Drelich, Xin Tong, et al.. (2020). Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro. mBio. 11(6). 66 indexed citations
10.
Li, Wei, Chuan Chen, Aleksandra Drelich, et al.. (2020). Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 117(47). 29832–29838. 52 indexed citations
11.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations
12.
Agrawal, Anurodh Shankar, Tianlei Ying, Xinrong Tao, et al.. (2016). Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Scientific Reports. 6(1). 31629–31629. 43 indexed citations
13.
Lokugamage, Kumari G., Krishna Narayanan, Keisuke Nakagawa, et al.. (2015). Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin. Journal of Virology. 89(21). 10970–10981. 113 indexed citations
14.
Agrawal, Anurodh Shankar, Tania Garron, Xinrong Tao, et al.. (2015). Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. Journal of Virology. 89(7). 3659–3670. 165 indexed citations
15.
Tao, Xinrong, Tania Garron, Anurodh Shankar Agrawal, et al.. (2015). Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. Journal of Virology. 90(1). 57–67. 65 indexed citations
16.
Tang, Jian, Naru Zhang, Xinrong Tao, et al.. (2015). Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus. Human Vaccines & Immunotherapeutics. 11(5). 1244–1250. 62 indexed citations
17.
18.
Tseng, Chien‐Te K., et al.. (2005). Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection. The Journal of Immunology. 174(12). 7977–7985. 112 indexed citations
19.
Tseng, Chien‐Te K. & Stewart Sell. (1991). Protracted Treponema pallidum -Induced Cutaneous Chancres in Rabbits Infected with Human T-Cell Leukemia Virus Type I. AIDS Research and Human Retroviruses. 7(3). 323–331. 6 indexed citations
20.
Lagoo, Anand S., Chien‐Te K. Tseng, & Stewart Sell. (1990). Interleukin 2 produced by activated B lymphocytes acts as an autocrine proliferation-inducing lymphokine. Cytokine. 2(4). 272–279. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Stalin Raj Breakdown of academic impact, for papers by Bo‐Jian Zheng Breakdown of academic impact, for papers by Jian‐Piao Cai Breakdown of academic impact, for papers by Julian L. Leibowitz Breakdown of academic impact, for papers by Katja C. Wolthers Breakdown of academic impact, for papers by Jie Zhou Breakdown of academic impact, for papers by Weijin Huang Breakdown of academic impact, for papers by Po Tien Breakdown of academic impact, for papers by Boyd L. Yount Breakdown of academic impact, for papers by Jacqueline D. Reeves
Rankless by CCL
2026